Clinical outcome after percutaneous treatment of de novo coronary bifurcation lesions using first or second generation of drug-eluting stents

Mirosław Ferenc(Universitäts-Herzzentrum Freiburg-Bad Krozingen), Franz–Josef Neumann(La Jolla Alcohol Research), Florian Riede(Universitäts-Herzzentrum Freiburg-Bad Krozingen), Aurel Toma(Medical University of Vienna), Christian Valina(Universitäts-Herzzentrum Freiburg-Bad Krozingen), Thomas Comberg(Universitäts-Herzzentrum Freiburg-Bad Krozingen), Heinz Joachim Buettner(Universitäts-Herzzentrum Freiburg-Bad Krozingen), Juergen Rothe(Universitäts-Herzzentrum Freiburg-Bad Krozingen), Piotr Kuebler(Universitäts-Herzzentrum Freiburg-Bad Krozingen), Michael Gick(Universitäts-Herzzentrum Freiburg-Bad Krozingen), Firas Khoury(Universitäts-Herzzentrum Freiburg-Bad Krozingen)
Clinical Research in Cardiology
September 1, 2015
10.1007/s00392-015-0911-7
Cited by 17

Related Papers

Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock
|New England Journal of Medicine|2012|2.8k
Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial
|The Lancet|2013|940
Prevention of Contrast Media–Associated Nephropathy
|Archives of Internal Medicine|2002|808
Early hypo-attenuated leaflet thickening in balloon-expandable transcatheter aortic heart valves
|European Heart Journal|2015|287
Inflammation and Long-Term Mortality After Non–ST Elevation Acute Coronary Syndrome Treated With a Very Early Invasive Strategy in 1042 Consecutive Patients
|Circulation|2002|252